Sunho Biologics,Inc. (2898) Income Statement

0 Followers

Sunho Biologics,Inc. Income Statement

Last quarter (Q2 2025), Sunho Biologics,Inc.'s total revenue was ¥17.00K, a decrease of -99.43% from the same quarter last year. In Q2, Sunho Biologics,Inc.'s net income was ¥-38.20M. See Sunho Biologics,Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 38.00K	¥ 17.53M	¥ 1.73M	¥ 3.22M
Gross Profit	¥ 38.00K	¥ 138.00K	¥ 473.00K	¥ 3.22M
Operating Expenses	¥ 101.39M	¥ 83.74M	¥ 46.68M	¥ 69.83M
Depreciation and Amortization	¥ 6.40M	¥ 8.64M	¥ 8.81M	¥ 2.40M
EBITDA	¥ -94.95M	¥ -123.37M	¥ -38.11M	¥ -64.21M
Operating Income	¥ -101.36M	¥ -66.21M	¥ -56.88M	¥ -66.62M
Other Income/Expenses	¥ 21.39M	¥ -66.49M	¥ 4.89M	¥ -4.02M
Pretax Income	¥ -79.97M	¥ -132.70M	¥ -51.99M	¥ -70.63M
Net Income	¥ -79.97M	¥ -132.70M	¥ -51.99M	¥ -70.63M
Per Share Metrics
Basic EPS	¥ -0.62	¥ -1.43	¥ -0.57	¥ -0.78
Diluted EPS	¥ -0.62	¥ -1.43	¥ -0.57	¥ -0.78
Weighted Average Shares Outstanding	128.98M	92.88M	91.21M	91.00M
Weighted Average Shares Outstanding (Diluted)	128.98M	92.88M	91.21M	91.00M

Currency in CNY

Sunho Biologics,Inc. (2898) Income Statement

Sunho Biologics,Inc. Income Statement

Sunho Biologics,Inc. Earnings and Revenue History